NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S

CVR 33249098 · Public limited company (A/S) · Dissolved after voluntary liquidation

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S is a Public limited company (A/S), founded on , based in Herlev. The company is registered in the industry forskning og eksperimentel udvikling indenfor bioteknologi. The company is no longer active (status: dissolved after voluntary liquidation). 10 annual reports have been published. The latest annual report (31 Dec 2018) shows equity of DKK 1.5m and a net result of DKK 954k.

Company details

CVR number
33249098
Status
Dissolved after voluntary liquidation
Company type
Public limited company (A/S)
Founded
Ceased
Address
Herlev Hovedgade 82
2730 Herlev
Municipality
Herlev
Industry
Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 500k
Auditor
Deloitte Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 9
Missing annual reportNo
Negative equityNo
Equity ratio16.6%
Current ratio120%
Moves (last 2 years)2
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address8
Going-concern uncertaintyNo

Financials and key figures

Financial year20182017
Gross profitDKK 1.3mDKK 2.9m
Net profitDKK 954kDKK 2.0m
EquityDKK 1.5mDKK 3.0m
Total assetsDKK 8.8mDKK 7.6m
CashDKK 36k–
Short-term debtDKK 7.3m–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2019 – 31 Dec 2019175
1 Jan 2018 – 31 Dec 2018159
1 Jan 2017 – 31 Dec 201799
1 Jan 2016 – 31 Dec 2016153
1 Jan 2015 – 31 Dec 201577
1 Jan 2014 – 31 Dec 2014159
1 Jan 2013 – 31 Dec 2013176
1 Jan 2012 – 31 Dec 2012162
1 Jan 2011 – 31 Dec 2011177
18 Oct 2010 – 31 Dec 2010157

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOBente Juel Christiansen
BoardClaus Henrik Christiansen
BoardThomas Nielsen
BoardMorten Asser Karsdal
Owner (100%)NBCD A/S
AuditorBrink Larse /Athos, Statsautoriseret Revisionsvirksomhed I/S
AuditorATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorAIDER Godkendt Revisionsaktieselskab
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderNORDIC BIOSCIENCE A/S

The CEOs' other companies

Bente Juel Christiansen – 22 other companies

Address history (2 moves)

Herlev Hovedgade 82, 2730 Herlev
Herlev Hovedgade 205, 2730 Herlev
Herlev Hovedgade 207, 2730 Herlev

Other companies at the same address

Similar companies in Herlev

Questions and answers about NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S

Has NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S gone bankrupt?

No, NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.

Who is the auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S?

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S most recently used Deloitte Statsautoriseret Revisionspartnerselskab.

When was NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S founded?

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S was founded on 18 October 2010.

What is the equity of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S?

Equity was DKK 1.5m according to the annual report for the period ending 31 December 2018.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.